LIBERTY PARTNERS GROUP, LLC

Lobbying for TELIX PHARMACEUTICALS US · Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Indiana · House · Senate · $40,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.